UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052346
Receipt number R000059761
Scientific Title Prospective Evaluation of Oocyte Yield After Granulocyte Colony-Stimulating Factor Priming in Women with Severe Diminished Ovarian Reserve: A Non-Randomized Clinical Investigation
Date of disclosure of the study information 2023/09/28
Last modified on 2025/01/20 16:40:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective, Non-Randomized Clinical Study on the Efficacy of Oocyte Retrieval Following G-CSF Priming in Cases with Severe Ovarian Reserve Insufficiency

Acronym

G-ORES (G-CSF Oocyte Retrieval Efficacy Study)

Scientific Title

Prospective Evaluation of Oocyte Yield After Granulocyte Colony-Stimulating Factor Priming in Women with Severe Diminished Ovarian Reserve: A Non-Randomized Clinical Investigation

Scientific Title:Acronym

PEORY-G (Prospective Evaluation of Oocyte Retrieval Yield with G-CSF)

Region

Japan


Condition

Condition

Infertility

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the success rate of oocyte retrieval in women diagnosed with Diminished Ovarian Reserve (DOR).

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Oocyte retrieval success rate in the subsequent cycle following G-CSF priming.

Key secondary outcomes

Cumulative oocyte retrieval success rate up to six months post-G-CSF treatment.
Cumulative pregnancy rate up to six months post-G-CSF treatment.
Follicular growth metrics observed after G-CSF priming.
Changes in Anti-Mullerian Hormone (AMH) levels post-G-CSF treatment.
Time duration from G-CSF injection to successful oocyte retrieval within six months post-treatment.
Time duration from G-CSF injection to clinical pregnancy confirmation within six months post-treatment.
Incidence of adverse events observed post-G-CSF administration.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Initiate the oocyte retrieval cycle following subcutaneous administration of 300ug of G-CSF (Filgrastim BS Injection 300ug Syringe F) during the early luteal phase.

Interventions/Control_2

Initiate the oocyte retrieval cycle without the use of G-CSF.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Female

Key inclusion criteria

Participants must be aged 20 years or older.
Participants must have a history of at least one cancelled oocyte retrieval cycle due to lack of follicular development.
Participants must be diagnosed with Diminished Ovarian Reserve (DOR) by a qualified physician.
Participants must have no prior history of pregnancy.
Participants must not have any other underlying medical conditions.
Participants must provide written informed consent, acknowledging an understanding of the study's objectives and procedures.

Key exclusion criteria

Participants experiencing mental instability or other factors that would make participation in the study difficult are excluded.

Target sample size

220


Research contact person

Name of lead principal investigator

1st name Shinnosuke
Middle name
Last name Komiya

Organization

HORAC Grand Front Osaka Clinic

Division name

Gynecology

Zip code

530-0011

Address

Grand Frront Osaka Tower B 15F, 3-1, Ofuka-cho, Kita-ku, Osaka city, Osaka, Japan

TEL

0636778824

Email

komiya0703@gmail.com


Public contact

Name of contact person

1st name Shinnosuke
Middle name
Last name Komiya

Organization

HORAC Grand Front Osaka Clinic

Division name

Gynecology

Zip code

530-0011

Address

Grand Frront Osaka Tower B 15F, 3-1, Ofuka-cho, Kita-ku, Osaka city, Osaka, Japan

TEL

0636778824

Homepage URL


Email

komiya0703@gmail.com


Sponsor or person

Institute

HORAC Grand Front Osaka Clinic

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

HORAC Grand Front Osaka Clinic

Address

Grand Frront Osaka Tower B 15F, 3-1, Ofuka-cho, Kita-ku, Osaka city, Osaka, Japan

Tel

0636778824

Email

komiya0703@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 09 Month 20 Day

Date of IRB

2024 Year 01 Month 01 Day

Anticipated trial start date

2024 Year 01 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 09 Month 28 Day

Last modified on

2025 Year 01 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059761